Search Results - "Gutiérrez, Asunción Echeveste"
-
1
Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies
Published in European journal of haematology (01-06-2019)“…Objectives To evaluate the safety and efficacy of maintenance therapy with the oral proteasome inhibitor ixazomib in patients with newly diagnosed multiple…”
Get full text
Journal Article -
2
A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma
Published in Haematologica (Roma) (01-09-2018)“…This phase I/II dose-escalation study investigated the all-oral ixazomib-melphalan-prednisone regimen, followed by single-agent ixazomib maintenance, in…”
Get full text
Journal Article -
3
Clinical and Epidemiological Characteristics of Multiple Myeloma (MM): Comparison Between Hematopoietic Stem Cell Transplantation (HSCT) and Conventional Chemotherapy
Published in Blood (18-11-2011)“…Abstract 4166 The purpose of this epidemiological retrospective study was to describe the natural history, clinical features, treatment and outcome of a wide…”
Get full text
Journal Article -
4
Epidemiological Study of Mutiple Myeloma In Spain: Efectiveness and Survival Analysis
Published in Blood (19-11-2010)“…Abstract 5044 Epidemiological studies are the base to evaluate the efficiency of medical interventions in the interest of the public health. Updated…”
Get full text
Journal Article -
5
Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis
Published in Journal of cancer research and clinical oncology (01-07-2017)“…Purpose The ENEST1st sub-analysis presents data based on Philadelphia chromosome (Ph) status, i.e., Ph+ and Ph−/ BCR-ABL1 + chronic myeloid leukemia. Methods…”
Get full text
Journal Article -
6
Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy
Published in European journal of haematology (01-04-2016)“…Therapeutic approaches against multiple myeloma (MM) have largely changed during the past decade. Hematopoietic stem cell transplantation (HSCT) and licensing…”
Get full text
Journal Article -
7
-
8
Efficacy and Safety of Long-Term Ixazomib Maintenance Therapy in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Not Undergoing Transplant: An Integrated Analysis of Four Phase 1/2 Studies
Published in Blood (08-12-2017)“…▪ Background There is increasing evidence for the clinical benefit of long-term, continuous therapy for NDMM pts. Proteasome inhibitors (PIs) form a backbone…”
Get full text
Journal Article